AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Estrogen improves memory, oral reading in midlife postmenopausal women.

Women's Health Weekly

| October 02, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 OCT 2 - (NewsRx.com & NewsRx.net) -- Midlife postmenopausal women who received daily treatment with estrogen showed improved oral reading and verbal memory performance, Yale School of Medicine researchers report in the September 2003 issue of the journal Menopause.

"This is the first study to specifically examine the effect of estrogen on reading ability," said principal investigator Sally Shaywitz, MD, professor of pediatrics and in the Yale Child Study Center. "The study also shows that estrogen may benefit younger postmenopausal women engaged in everyday activities, such as reading. It should encourage physicians caring for postmenopausal women to inquire about and take seriously concerns about difficulties in reading and in memory."

The study was a randomized, double-blind, placebo-controlled trial of a group of 60 postmenopausal women ages 32.8 to 64.9. Participants were evaluated for oral reading, verbal memory, and other cognitive skills. They were treated for two periods of 21 days each: one period with estrogen and after waiting 14 days, another period with placebo.

Shaywitz obtained data on oral reading using the Gray Oral Reading Test and on verbal memory using the Wechsler Memory Scales and the Sentence Span Test. Mood was assessed with the Beck Depression Inventory and no significant difference was recorded between placebo- and estrogen-treated subjects. Vocabulary, attention, and nonverbal memory were comparable in placebo and estrogen ...

Related articles from newspapers, magazines, journals, and more
Estrogen improves memory, oral reading in midlife postmenopausal women.
Newspaper article from: Pain & Central Nervous System Week September 29, 2003 700+ words
...Midlife postmenopausal women who received...improved oral reading and verbal...group of 60 postmenopausal women ages 32...evaluated for oral reading, verbal...effects on oral reading and verbal...in midlife postmenopausal women. The new...
Estrogen improves verbal memory, oral reading in younger postmenopausal women.
Magazine article from: Women's Health Weekly October 16, 2003 700+ words
...Midlife postmenopausal women who received...improved oral reading and verbal...group of 60 postmenopausal women ages 32...evaluated for oral reading, verbal...effects on oral reading and verbal...in midlife postmenopausal women. The new...
Health issues in postmenopausal women who drink.
Alcohol Research & Health Register, Thomas C. Cline, J. Mark Shively, Carol A. December 22, 2002 700+ words
...these three diseases in postmenopausal women. The authors stress...potential health effects in postmenopausal women should be interpreted...and well. being of postmenopausal women through the direct...
FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The...
Press release article from: PR Newswire September 14, 2007 700+ words
...reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS...breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast...
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk...
Press release article from: PR Newswire July 24, 2007 700+ words
...provide an important option for postmenopausal women at increased risk for breast cancer...cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...
ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER THAN EVISTA.
News wire article from: AsiaPulse News March 24, 2009 700+ words
...raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS, Mar 23...Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly and...and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive...
Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
Press release article from: PR Newswire December 10, 2002 700+ words
...treatment-related bone loss in postmenopausal women with early breast cancer Novartis...associated with cancer treatment in postmenopausal women with early breast cancer. The Novartis...benefit from this information -- postmenopausal women receiving aromatase inhibitor therapy...
Special Feature: Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs...
Magazine article from: OB/GYN Clinical Alert January 1, 2004 700+ words
...Feature Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs Expectant Management...and required surgical resection. Postmenopausal women werent supposed to have ovarian...evidence that the vast majority of postmenopausal women with unilocular ovarian cysts up...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA